I WOULDN’T GIVE MY ANIMALS NOTHING I WOULDN’T GIVE MYSELF. During phase one, animals were dosed with the compound, with one group receiving 1,000 milligrams per kilogram, and a second receiving 2,000 milligrams per kilogram. All animals at both dose levels demonstrated no negative impacts during the post-observation period.
This indicates that the compound could be a potential medical breakthrough for treatment of human-contracted pathogens.